Doctors Research Group Receives FDA Clearance for Kryptonite Bone Cement

Doctors Research Group has received 510(k) approval from the FDA to market its Kryptonite Bone Cement for cranioplasty applications, according to a release from Doctors Research Group.

Advertisement

The product is the first non-toxic, low-exotherm cement and bone void filler approved for cranioplasty applications.

Read the release on Doctors Research Group’s Kryptonite Bone Cement.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.